Effects of Depression Diagnosis and Antidepressant Treatment on Mortality in Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease

被引:32
作者
Qian, Jingjing [1 ]
Simoni-Wastila, Linda [2 ,3 ]
Langenberg, Patricia [4 ]
Rattinger, Gail B. [5 ]
Zuckerman, Ilene H. [2 ,3 ]
Lehmann, Susan [6 ]
Terrin, Michael [4 ]
机构
[1] Auburn Univ, Harrison Sch Pharm, Dept Pharm Care Syst, Auburn, AL 36849 USA
[2] Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Pharm, Peter Lamy Ctr Drug Therapy & Aging, Baltimore, MD 21201 USA
[4] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA
[5] Fairleigh Dickinson Univ, Pharm Practice Div, Sch Pharm, Florham Pk, NJ USA
[6] Johns Hopkins Univ Hosp, Geriatr Psychiat Clin, Baltimore, MD 21287 USA
基金
美国国家卫生研究院;
关键词
depression; antidepressant treatment; Medicare beneficiaries; SSDI eligibility; chronic obstructive pulmonary disease; ELDERLY-PATIENTS; COPD PATIENTS; ANXIETY; IMPACT; PREVALENCE; SYMPTOMS; RISK; CARE; HOSPITALIZATION; EXACERBATIONS;
D O I
10.1111/jgs.12220
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
030301 [社会学]; 100201 [内科学];
摘要
Objectives To estimate the effects of depression diagnosis and antidepressant treatment on 2-year all-cause mortality in Medicare beneficiaries with chronic obstructive pulmonary disease (COPD) and determine whether Social Security Disability Insurance (SSDI) eligibility modifies these relationships. Design Retrospective cohort study. Setting A 5% random sample of Medicare beneficiaries aged 65 and older in stand-alone Part D plans in 2006 to 2008. Participants Beneficiaries diagnosed with COPD and continuously enrolled in Medicare Parts A, B, and D (N=75,699). Measurements Depression diagnosis was assessed at baseline (2006). Evidence of antidepressant treatment was measured across time. Covariates included baseline characteristics, comorbidities, and disease severity. Survival analyses using Cox proportional hazards models estimated 2-year mortality associated with depression diagnosis or antidepressant treatment (in beneficiaries with depression). Interaction terms of SSDI eligibility with baseline depression and time-dependent antidepressant treatment were tested. Results More than one-fifth (21.6%) of beneficiaries with COPD had a depression diagnosis at baseline, and 82.1% of those received antidepressants. Nearly one-sixth (16.3%) of the sample were SSDI eligible. Baseline depression heightened risk of death (hazard ratio=1.13, 95% confidence interval=1.091.18) in beneficiaries who were not eligible for SSDI. In beneficiaries with depression, the association between antidepressant treatment and lower mortality was different according to SSDI eligibility status. Conclusion Social Security Disability Insurance eligibility modifies the effects of depression and antidepressant treatment on mortality in Medicare beneficiaries with COPD. These data suggest that clinicians should identify and treat depression in individuals with COPD, but further studies are needed to determine the effect of these interventions.
引用
收藏
页码:754 / 761
页数:8
相关论文
共 40 条
[1]
Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD [J].
Al-shair, Khaled ;
Dockry, Rachel ;
Mallia-Milanes, Brendan ;
Kolsum, Umme ;
Singh, Dave ;
Vestbo, Jorgen .
RESPIRATORY MEDICINE, 2009, 103 (10) :1572-1579
[2]
Mortality after hospitalization for COPD [J].
Almagro, P ;
Calbo, E ;
de Echagüen, AO ;
Barreiro, B ;
Quintana, S ;
Heredia, JL ;
Garau, J .
CHEST, 2002, 121 (05) :1441-1448
[3]
Comorbidities, Patient Knowledge, and Disease Management in a National Sample of Patients with COPD [J].
Barr, R. Graham ;
Celli, Bartolome R. ;
Mannino, David M. ;
Petty, Thomas ;
Rennard, Stephen I. ;
Sciurba, Frank C. ;
Stoller, James K. ;
Thomashow, Byron M. ;
Turino, Gerard M. .
AMERICAN JOURNAL OF MEDICINE, 2009, 122 (04) :348-355
[4]
IMPROVEMENT IN MOOD, PHYSICAL SYMPTOMS, AND FUNCTION WITH NORTRIPTYLINE FOR DEPRESSION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
BORSON, S ;
MCDONALD, GJ ;
GAYLE, T ;
DEFFEBACH, MPHM ;
LAKSHMINARAYAN, S ;
VANTUINEN, C .
PSYCHOSOMATICS, 1992, 33 (02) :190-201
[5]
Buccaneer Computer Systems & Services Inc., 2010, CHRON COND DAT WAR D
[6]
Centers for Disease Control and Prevention, 2010, DEATHS PREL DAT 2008
[7]
Disability and health care costs in the medicare population [J].
Chan, L ;
Beaver, S ;
MacLehose, RF ;
Jha, A ;
Maciejewski, M ;
Doctor, JN .
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2002, 83 (09) :1196-1201
[8]
Medicare Doesn't Work As Well For Younger, Disabled Beneficiaries As It Does For Older Enrollees [J].
Cubanski, Juliette ;
Neuman, Patricia .
HEALTH AFFAIRS, 2010, 29 (09) :1725-1733
[9]
A retrospective analysis of disability and its related costs among employees with chronic obstructive pulmonary disease [J].
Darkow, Theodore ;
Kadlubek, Pamela J. ;
Shah, Hernal ;
Phillips, Amy L. ;
Marton, Jeno P. .
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2007, 49 (01) :22-30
[10]
Depression is a risk factor for noncompliance with medical treatment -: Meta-analysis of the effects of anxiety and depression on patient adherence [J].
DiMatteo, MR ;
Lepper, HS ;
Croghan, TW .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (14) :2101-2107